SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns 
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany 
BURLINGTON, Mass., May 03, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting in three conferences in May.
David Roberts, President, is scheduled to present at the Deutsche Bank Healthcare Conference on Tuesday, May 8, 2018 at the InterContinental Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 10:40 AM EDT.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Conference on Wednesday, May 9, 2018 at the Boston Park Plaza Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 11:10 AM EDT.
David Roberts, President, is scheduled to present at the UBS Healthcare Conference on Tuesday, May 22, 2018 at the Grand Hyatt New York Hotel in New York City. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
